Guro, KR Orthopedic Stem Cell Therapy For Back Pain: New Treatments Announced

Lydian Cosmetic Surgery Clinic has announced new orthopedic stem cell therapy treatments for foreigners in South Korea’s Guro District. The latest treatments are designed to address musculoskeletal issues.

-- The practice is now offering its latest stem cell therapy treatments as a less invasive alternative to surgery. Visitors and foreigners currently living in the Guro District who suffer from lower back pain and other musculoskeletal disorders can contact the clinic to determine whether the treatment is appropriate for them.

For more information, please visit https://www.lydianclinic.com/blog/stem-cell-therapy-cost-back-pain-korea-2025/

Lower back pain is one of the most common musculoskeletal conditions worldwide and is currently the leading cause of disability. According to statistics from the World Health Organization, lower back pain affected 619 million people around the world in 2020, and this number is expected to increase to 843 million by 2050 due to population expansion and aging.

Traditionally, back pain is managed with exercise and physical therapy as the first line of treatment. If non-medical approaches fail, patients may turn to pain medications or surgery; however, these methods carry risks of addiction and infection, respectively, and generally only address the symptom of the problem, rather than the cause. For this reason, many experts in the medical community have begun considering orthopedic stem cell therapy as an alternative, as it is less invasive and focuses on naturally regenerating the tissue, rather than masking the pain.

As Lydian Cosmetic Surgery Clinic explains, stem cell surgery uses the patient’s own stem cells, which are typically derived from adipose tissue or bone marrow, to repair damaged cartilage and tissues. The treatment is highly localized; the cells are injected directly into the affected area to stimulate healthy cell growth in damaged tissues. This typically results in improved mobility and a reduction in chronic pain and inflammation without hospitalization or long recovery times; additionally, because the tissue itself is healed, patients will ultimately rely less on pain medications and other treatments.

Lydian Cosmetic Surgery Clinic uses mesenchymal stem cells (MSCs) to treat spinal conditions, as they are well-tolerated and known to be effective. The cells are harvested from the patient before being purified and concentrated in FDA-compliant cell processing labs. These cells are then injected with ultrasound or fluoroscopy guidance to ensure precision and patient safety.

Because the procedure is non-invasive, patients can resume daily activities within three days. Lydian Cosmetic Surgery Clinic notes that many will experience gradual improvements in their symptoms over several weeks.

Interested parties can learn more by visiting https://www.lydianclinic.com/blog/stem-cell-therapy-cost-back-pain-korea-2025/

Contact Info:
Name: Dr. Abraham An
Email: Send Email
Organization: Lydian Cosmetic Surgery Clinic
Address: 836 Nonhyeon-ro, Sinsa-dong, Gangnam, Seoul, Seoul 06025, Korea, Republic of
Website: https://www.lydianclinic.com/

Source: NewsNetwork

Release ID: 89185283

In the event of any inaccuracies, problems, or queries arising from the content shared in this press release, we encourage you to notify us immediately at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our diligent team will be readily available to respond and take swift action within 8 hours to rectify any identified issues or assist with removal requests. Ensuring the provision of high-quality and precise information is paramount to us.

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  213.21
-5.73 (-2.62%)
AAPL  257.46
-2.83 (-1.09%)
AMD  192.43
-7.02 (-3.52%)
BAC  48.64
-0.89 (-1.80%)
GOOG  298.30
-2.61 (-0.87%)
META  644.86
-15.71 (-2.38%)
MSFT  408.65
-2.03 (-0.49%)
NVDA  177.82
-5.52 (-3.01%)
ORCL  152.96
-1.83 (-1.18%)
TSLA  396.73
-8.82 (-2.17%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.